Drug Shortage Report for TARKA
Report ID | 58217 |
Drug Identification Number | 02238097 |
Brand name | TARKA |
Common or Proper name | Trandolapril/Verapamil Hydrochloride Sustained-Release Tablets |
Company Name | BGP PHARMA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | VERAPAMIL HYDROCHLORIDE TRANDOLAPRIL |
Strength(s) | 240MG 4MG |
Dosage form(s) | TABLET (EXTENDED-RELEASE) |
Route of administration | ORAL |
Packaging size | BT 100 |
ATC code | C09BB |
ATC description | ACE INHIBITORS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-01-31 |
Actual start date | |
Estimated end date | |
Actual end date | 2019-11-19 |
Shortage status | Resolved |
Updated date | 2020-02-19 |
Company comments | Discontinued in ID 106670. Last lot 1063250 Exp 2019-04-01 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-02-19 | French | Compare |
v4 | 2020-02-19 | English | Compare |
v3 | 2019-02-01 | English | Compare |
v2 | 2018-08-15 | French | Compare |
v1 | 2018-08-15 | English | Compare |
Showing 1 to 5 of 5